Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 1Gynecologic 1

Conditions

Ovarian Neoplasms 106Fallopian Tube Neoplasms 48Carcinoma, Ovarian Epithelial 31Uterine Cervical Neoplasms 28Pancreatic Neoplasms 13Endometrial Neoplasms 13Neoplasms 10Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 10Recurrence 7Prostatic Neoplasms 7Neoplasm Metastasis 7Lung Neoplasms 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Sarcoma 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Peritoneal Neoplasms 5Cholangiocarcinoma 5Small Cell Lung Carcinoma 4Melanoma 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Colonic Neoplasms 4Vulvar Neoplasms 3Uterine Neoplasms 3Multiple Myeloma 3Carcinoma 3

Interventions

Cisplatin 3pembrolizumab 2amminedichloro(2-methylpyridine)platinum(II) 2Nivolumab 2Cytoreduction Surgical Procedures 2trastuzumab deruxtecan 1trametinib 1sodium thiosulfate 1pertuzumab 1pazopanib 1osimertinib 1motexafin gadolinium 1fludarabine 1danvatirsen 1dabrafenib 1cobimetinib 1cemiplimab 1alectinib 1aldesleukin 1X-Rays 1Ritonavir 1Remote Patient Monitoring 1Patient-Specific Modeling 1Pafolacianine 1Oxaliplatin 1Observation 1Mitomycin 1Microscopy, Electron 1Itraconazole 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Gemcitabine × Gynecologic × Clear all
NCT00390182 2020-03-18

GCC0319

University of Maryland, Baltimore

Phase 1/2 Completed
38 enrolled 9 charts
GastrointestinalGynecologic

Gastrointestinal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡